Newsbenzinga
Vivos Therapeutics Announces Exchange Of $2,861,270 Of Streeterville Note Principal For 11,445,080 Common Shares At $0.25/Share
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…